Tablet formulation
    1.
    发明授权
    Tablet formulation 失效
    片剂制剂

    公开(公告)号:US4209513A

    公开(公告)日:1980-06-24

    申请号:US896297

    申请日:1978-04-14

    IPC分类号: A61K9/20 A61K31/505 A61K47/00

    摘要: A tablet suitable for use in the treatment of microbial infections, which tablet comprises from 80 to 98% (w/w) of a combination of a 2,4-diaminopyrimidine with a sulphonamide and not more than 20% (w/w) of both a granulating and a disintegrating agent, the combination having a particle size less than 40 .mu.m and the disintegrating agent having a swelling capacity greater than 5 ml/g.

    摘要翻译: 适合用于治疗微生物感染的片剂,该片剂包含80-98%(w / w)的2,4-二氨基嘧啶与磺酰胺和不超过20%(w / w)的 造粒剂和崩解剂,粒径小于40μm的组合物和溶胀能力大于5ml / g的崩解剂。